These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8540508)

  • 1. Talc in the liver of patients with chronic hepatitis C infection.
    Sherman KE; Lewey SM; Goodman ZD
    Am J Gastroenterol; 1995 Dec; 90(12):2164-6. PubMed ID: 8540508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
    Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection.
    Strasser SI; Watson KJ; Lee CS; Coghlan PJ; Desmond PV
    Med J Aust; 1995 Apr; 162(7):355-8. PubMed ID: 7715515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with chronic hepatitis C virus infection: limited frequency of an unidentified source of transmission.
    Flamm SL; Parker RA; Chopra S
    Am J Gastroenterol; 1998 Apr; 93(4):597-600. PubMed ID: 9576454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C in patients with sickle cell disease.
    Hasan MF; Marsh F; Posner G; Bellevue R; Dosik H; Suatengco R; Ramani N
    Am J Gastroenterol; 1996 Jun; 91(6):1204-6. PubMed ID: 8651171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.
    Rosen HR; Chou S; Sasaki AW; Gretch DR
    Am J Gastroenterol; 1999 Oct; 94(10):3015-9. PubMed ID: 10520862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of hepatitis C virus infection in a suburban Detroit community.
    Meyer RA; Gordon SC
    Am J Gastroenterol; 1991 Sep; 86(9):1224-6. PubMed ID: 1652886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.
    Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD
    Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HCV IgG avidity index in acute hepatitis C.
    Coppola N; Pisapia R; Marrocco C; Martini S; Vatiero LM; Messina V; Tonziello G; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    J Clin Virol; 2007 Oct; 40(2):110-5. PubMed ID: 17720621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
    McCormick SE; Goodman ZD; Maydonovitch CL; Sjogren MH
    Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
    García-Samaniego J; Soriano V; Castilla J; Bravo R; Moreno A; Carbó J; Iñiguez A; González J; Muñoz F
    Am J Gastroenterol; 1997 Jul; 92(7):1130-4. PubMed ID: 9219784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States.
    Balasekaran R; Bulterys M; Jamal MM; Quinn PG; Johnston DE; Skipper B; Chaturvedi S; Arora S
    Am J Gastroenterol; 1999 May; 94(5):1341-6. PubMed ID: 10235216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.